Melatonin: Clinical Evidence & Substantiation Summary
What Is Melatonin?
Melatonin is a hormone naturally produced by the pineal gland that regulates circadian rhythm and sleep-wake cycles. It is the most widely used sleep supplement globally, with strong evidence for sleep onset, jet lag, and shift work support.
Mechanism of action: Melatonin binds to MT1 and MT2 receptors in the suprachiasmatic nucleus (SCN), the brain's master circadian clock. It promotes sleep onset by lowering core body temperature and reducing alerting signals. It also has antioxidant properties and can modulate immune function.
Clinical Evidence Summary
Below are 5 key clinical studies on Melatonin. Nutra Comp analyses 112+ studies in its full clinical evidence report.
Melatonin for primary sleep disorders: a meta-analysis
Population: 19 RCTs, 1,683 participants
Key finding: Melatonin significantly reduced sleep onset latency (-7.06 min, p<0.001), increased total sleep time (+8.25 min), and improved sleep quality.
Melatonin and jet lag: systematic review
Population: 10 RCTs
Key finding: Melatonin (0.5–5 mg at bedtime at destination) significantly reduced jet lag symptoms, particularly for eastward travel crossing 5+ time zones.
Low-dose melatonin for sleep in older adults
Population: 14 RCTs
Key finding: Low-dose melatonin (0.5–2 mg) significantly improved sleep onset and quality in adults over 55 with minimal side effects.
Melatonin and circadian rhythm disorders
Population: 12 RCTs
Key finding: Melatonin was significantly more effective than placebo for delayed sleep-wake phase disorder (DSWPD) and shift work sleep problems.
Antioxidant properties of melatonin: clinical evidence
Population: Clinical studies
Key finding: Melatonin demonstrated antioxidant effects at physiological doses, scavenging free radicals and stimulating antioxidant enzyme activity.
Evidence-Based Structure–Function Claims
Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.
Get the full substantiation report for Melatonin
Includes all 112+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.
Join Waitlist for Full AccessRelated Ingredients
Key Terms
Frequently Asked Questions
Is melatonin FDA approved?
In the US, melatonin is sold as a dietary supplement and does not require FDA approval. In many European countries, it is sold as a prescription medication (Circadin®).
What are the most studied benefits?
The strongest evidence supports melatonin for improving sleep onset latency, managing jet lag, and supporting circadian rhythm in shift workers and older adults.
What dosage is used?
Most studies use 0.5–5 mg taken 30–60 minutes before bedtime. Lower doses (0.5–1 mg) may be more physiological and cause fewer next-day grogginess issues. More is not necessarily better.
Stop Spending Weeks on Substantiation
Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.
Join the Waitlist